Phase 3 Randomized, Placebo-Controlled Study of Galcanezumab in Patients with Chronic Cluster Headache: Results from 3-Month Double-Blind Treatment.
HEADACHE（2019）
Key words
Galcanezumab,chronic cluster headache,LY2951742,CGRP,humanized monoclonal antibody
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined